Journal of Clinical Oncology, Vol 12, 1266-1271, Copyright © 1994 by American Society of Clinical Oncology

ARTICLES

Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study

PC Clahsen, CJ van de Velde, JP Julien, JL Floiras and FY Mignolet
European Organization for Research and Treatment of Cancer Data Center, Brussels, Belgium.

PURPOSE AND METHODS: Data from a randomized phase III trial in early breast cancer, comparing surgery followed by one short intensive course of perioperative fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus surgery alone, were analyzed for the occurrence of thromboembolic complications within 6 weeks after surgery. RESULTS: Twenty-seven of 1,292 patients assigned to the perioperative chemotherapy treatment arm (2.1%) and 10 of 1,332 patients on observation (0.8%) developed thromboembolic events (P = .004). The frequency of thromboembolic complications was higher among postmenopausal women compared with premenopausal women (2.0% v 0.6%, P = .003). Patients who had mastectomy had a higher frequency of thromboembolic disease than those who had tumorectomy (2.3% v 0.7%, P < .001). Three deaths occurred after pulmonary embolism, all of them in the perioperative chemotherapy treatment arm. CONCLUSION: These results suggest a contributing role of perioperative chemotherapy to thromboembolic disease, especially in postmenopausal women and women undergoing mastectomy. Antithrombosis prophylaxis should be considered in the case of adjuvant perioperative chemotherapy.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. A. Khorana and G. C. Connolly Assessing Risk of Venous Thromboembolism in the Patient With Cancer J. Clin. Oncol., October 10, 2009; 27(29): 4839 - 4847. [Abstract] [Full Text] [PDF]

				H. K. Chew, T. Wun, D. J. Harvey, H. Zhou, and R. H. White Incidence of Venous Thromboembolism and the Impact on Survival in Breast Cancer Patients J. Clin. Oncol., January 1, 2007; 25(1): 70 - 76. [Abstract] [Full Text] [PDF]

				J. Woodley-Cook, L. Y.Y. Shin, L. Swystun, S. Caruso, S. Beaudin, and P. C. Liaw Effects of the chemotherapeutic agent doxorubicin on the protein C anticoagulant pathway Mol. Cancer Ther., December 1, 2006; 5(12): 3303 - 3311. [Abstract] [Full Text] [PDF]

				M. Adess, R. Eisner, S. Nand, J. Godwin, H. L. Messmore Jr, and W. H. Wehrmacher Thromboembolism in Cancer Patients: Pathogenesis and Treatment Clinical and Applied Thrombosis/Hemostasis, July 1, 2006; 12(3): 254 - 266. [Abstract] [PDF]

				H.-M. M. B. Otten, J. Mathijssen, H. ten Cate, M. Soesan, M. Inghels, D. J. Richel, and M. H. Prins Symptomatic Venous Thromboembolism in Cancer Patients Treated With Chemotherapy: An Underestimated Phenomenon Arch Intern Med, January 26, 2004; 164(2): 190 - 194. [Abstract] [Full Text] [PDF]

				F. A. Anderson Jr. and F. A. Spencer Risk Factors for Venous Thromboembolism Circulation, June 17, 2003; 107(90231): I-9 - 16. [Abstract] [Full Text] [PDF]

				A. Y.Y. Lee and M. N. Levine Venous Thromboembolism and Cancer: Risks and Outcomes Circulation, June 17, 2003; 107(90231): I-17 - 21. [Abstract] [Full Text] [PDF]

				J. A. van der Hage, C. J.H. van de Velde, J.-P. Julien, M. Tubiana-Hulin, C. Vandervelden, and L. Duchateau Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902 J. Clin. Oncol., November 15, 2001; 19(22): 4224 - 4237. [Abstract] [Full Text]

				P. H. M. Elkhuizen, H.-J. van Slooten, P. C. Clahsen, J. Hermans, C. J. H. van de Velde, L. C. J. M. van den Broek, and M. J. van de Vijver High Local Recurrence Risk After Breast-Conserving Therapy in Node-Negative Premenopausal Breast Cancer Patients Is Greatly Reduced by One Course of Perioperative Chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study J. Clin. Oncol., March 1, 2000; 18(5): 1075 - 1075. [Abstract] [Full Text] [PDF]

				A. Letai and D. J. Kuter Cancer, Coagulation, and Anticoagulation Oncologist, December 1, 1999; 4(6): 443 - 449. [Abstract] [Full Text]

				G.-F. von Tempelhoff, K. Pollow, D. Schneider, and L. Heilmann State-of-the-Art Review : Chemotherapy and Thrombosis in Gynecologic Malignancy Clinical and Applied Thrombosis/Hemostasis, April 1, 1999; 5(2): 92 - 104. [PDF]

				L. Heilmann, G.-F. V. Tempelhoff, and D. Schneider State-of the-Art Review : Prevention of Thrombosis in Gynecologic Malignancy Clinical and Applied Thrombosis/Hemostasis, July 1, 1998; 4(3): 153 - 159. [PDF]